Pharmacokinetics of Favipiravir in Critically Ill Patients With COVID‐19

Since December 2019, a novel coronavirus (severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2)) infection has been rapidly spreading worldwide and causing the respiratory illness, coronavirus disease 2019 (COVID‐19). The antiretroviral drug favipiravir (FPV) has been experimentally used for...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Transl Sci
Main Authors: Irie, Kei, Nakagawa, Atsushi, Fujita, Hirotoshi, Tamura, Ryo, Eto, Masaaki, Ikesue, Hiroaki, Muroi, Nobuyuki, Tomii, Keisuke, Hashida, Tohru
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7300626/
https://ncbi.nlm.nih.gov/pubmed/32475019
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cts.12827
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados